- Adapting negotiation strategies to allow for future merger and acquisition opportunities.
- Strategically planning the deal, gauging value, and structuring compensation in the face of increased competition for early-stage products.
- Leveraging and safeguarding intellectual property rights during negotiations.
- Exploring the potentially damaging impact of MedIimmune v. Genentech.
- Ensuring the agreement includes flexible and scalable methodologies for assessing the value of multiple indications.
- Fine-tuning due diligence processes to identify and minimize risks.
- Successfully negotiating collaborative research.
Two additional master classes will be offered on July 18, 2007. The morning class is entitled: "Negotiating Industry/University Collaborations: Ethical and Practical Strategies for Maximizing Return on Investment," and the afternoon class is entitled: "The "Win-Win" Collaborative Agreement: Ethical and Practical Negotiating and Drafting Strategies."
The agenda for the Technology IP Due Diligence conference can be found here. A complete brochure for this conference, including an agenda, list of speakers, and registration form can be downloaded here.
The registration fee ranges from $1,995 (conference alone) to $2,595 (conference and one master class) or $3,195 (conference and both master classes). Those registering on or before June 15, 2007 will receive a $200 discount off the registration fee. Those interested in registering for the conference can do so here or by calling 1-888-224-2480.
Patent Docs is a media sponsor of ACI's Pharma and Biotech Collaborative Agreements conference.
Comments